InsidersTradesSigma
Follow the HK이노엔 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, HK이노엔 has published 34 insider filings. Market capitalisation: €1,029.8bn. The latest transaction was reported on 1 July 2026 (Sale). Among the most active insiders: 국민연금공단. The full history is openly available.
33
Insider Decl.
n/a
Thresholds
€55,372
11 ops.
Buy Volume
n/a
17 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HK이노엔 Buy (bullish), based on 12 analysts. Average price target: ₩65,500.
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,799 of 29,051 companies
56.6
score / 100
Value65
Quality49
FCF yld6.1%
Earn yld6.1%
EV/EBITDA11.5x
ROE3.9%
Gross mgn46%
Net mgn7.1%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 July 2026
Declarations34 total
Other
319,805 sharesKRXDART:20240809000510
25 of 34 declarations
About HK이노엔
HK이노엔 is a company operating in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and commercialization of innovative pharmaceutical products.